Clinical Trial Update: Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating neoadjuvant radiochemotherapy combined with cadonilizumab for locally advanced esophageal squamous cell carcinoma; currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Cadonilizumab (Cadonilizumab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING